Mylan (Switzerland)

Mylan (Switzerland)

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Mylan (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

54%


Total
Publications

2.1K


Total Open
Publications

1.2K


Total
Citations

92K


Open Access
Percentage

54%


Total
Publications

2.1K


Total Open
Publications

1.2K


Total
Citations

92K

Wikipedia

Website

download

Breakdown

20% 20% 13% 47%

Publisher Open

20%

Both

20%

Other Platform Open

13%

Closed

47%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

40%OA Journal

OA Journal 40%

335

Hybrid 28%

236

No Guarantees 32%

264

Other Platform Open

Institution 80%

571

Domain 19%

132

Other Internet 13%

90

Preprint 5%

34

Public 3%

19

Other Platform Locations

Name

Platform Type

Publications

University of Milan
Institution
217
PubMed Central
Domain
132
University of Castilla-La Mancha
Institution
120
DOI
Other Internet
76
University of Milano-Bicocca
Institution
73
European Organization for Nuclear Research
Institution
53
University of Modena and Reggio Emilia
Institution
27
Istituto di Ematologia di Bologna
Institution
22
Office of Scientific and Technical Information
Institution
19
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
19
1 / 11

Data updated 18 August 2025

Share

Share

Share